THURSDAY, Jan. 6, 2022 (HealthDay News) — The Abbott BinaxNOW and Quidel QuickVue — two widely used rapid at-home COVID tests — may sometimes fail to spot evidence of the Omicron variant in the first days after infection, even when people are carrying substantial levels of the virus, preliminary researchContinue Reading
THURSDAY, Jan. 6, 2022 (HealthDay News) — British Prime Minister Boris Johnson on Wednesday announced that pre-departure tests for people traveling to the United Kingdom will no longer be required because restrictions meant to contain the international spread of the highly contagious Omicron variant are now meaningless. The change shouldContinue Reading
WEDNESDAY, Jan. 5, 2022 (HealthDay News) — The U.S. Centers for Disease Control and Prevention on Wednesday endorsed the emergency use of Pfizer’s booster shots for children ages 12 to 17, expanding protection to adolescents and teens as students return to classes and the highly contagious Omicron variant surges acrossContinue Reading
WEDNESDAY, Jan. 5, 2022 (HealthDay News) — Your at-home COVID-19 test could now come with a higher price tag, depending on where you buy it. Kroger and Walmart stores were selling the test kits at cost or at a discount of up to 35% for 100 days after making aContinue Reading
WEDNESDAY, Jan. 5, 2021 (HealthDay News) – Be concerned about the rapidly spreading Omicron variant, President Joe Biden urged Americans on Tuesday, but don’t be alarmed. Biden delivered that message to reporters prior to a meeting with his COVID-19 response team, saying he was trying to convey both his administration’sContinue Reading
WEDNESDAY, Jan. 5, 2022 (HealthDay News) — While the Omicron variant appears wily enough to evade people’s antibodies, researchers report that it should have a much harder time slipping past a person’s T-cells. “Despite being a preliminary study, we believe this is positive news. Even if Omicron, or some otherContinue Reading
TUESDAY, Jan. 4, 2022 (HealthDay News) — The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of Pfizer’s booster shot for high-risk kids between the ages of 5 and 11, along with shortening the time period between a second dose and a booster shotContinue Reading
TUESDAY, Jan. 4, 2022 (HealthDay News) — COVID-19 hospitalizations among children are surging across the United States just as students return to school and the highly transmissible Omicron variant begins to dominate the country. At least nine states have reported record numbers of COVID-related pediatric hospitalizations: They include Connecticut, Georgia,Continue Reading
MONDAY, Jan. 3, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer’s booster shot against COVID-19 for youths aged 12 to 15. The move comes as the Omicron variant spreads across the country and students return to classrooms following the holidayContinue Reading
MONDAY, Jan. 3, 2022 (HealthDay News) – Right now, Americans who have tested positive for COVID-19 but have no symptoms are advised by the U.S. Centers for Disease Control and Prevention to isolate for five days and then wear a mask for another five days when around others. But theyContinue Reading